Michael Scott Habig's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 18,249 Common Stock done at an average price of $5.3 . Disclosure was reported to the exchange on Aug. 6, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc | Scott Michael Habig | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.31 per share. | 06 Aug 2024 | 18,249 | 456,338 (0%) | 0% | 5.3 | 96,902 | Common Stock |
| Aurinia Pharmaceuticals Inc | Scott Michael Habig | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 06 Mar 2024 | 17,777 | 474,587 (0%) | 0% | 5.6 | 99,551 | Common Stock |
| Aurinia Pharmaceuticals Inc | Michael Scott Habig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 195,512 | 508,231 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharmaceuticals Inc | Michael Habig Scott | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.48 per share. | 20 Feb 2024 | 15,867 | 492,364 (0%) | 0% | 5.5 | 86,951 | Common Stock |
| Aurinia Pharmaceuticals Inc | Scott Michael Habig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 170,188 | 312,719 (0%) | 0% | - | Common Stock | |
| Aurinia Pharmaceuticals Inc | Scott Michael Habig | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 5.02 per share. | 09 Nov 2022 | 5,000 | 5,000 (0%) | 0% | 5.0 | 25,075 | Common Stock |
| Aurinia Pharmaceuticals Inc | Scott Michael Habig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 231,203 | 231,203 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Scott Michael Habig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 137,531 | 137,531 | - | - | Restricted Stock Units |